๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Non-Hodgkin's Lymphoma
Clinical trial register · China

Non-Hodgkin's Lymphoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 9 Hangzhou 3 Haerbin 1 Qingdao 1 Dongyang 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing9 Hangzhou3 Haerbin1 Qingdao1 Dongyang1
All 18 locations
Target enrolment
to

Non-Hodgkin's Lymphoma trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
NCT07620314Non-Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1
9
Beijing
2026-07-16
Recruiting
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
NCT06520163Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University
Phase 3
99
Dongyang, Hangzhou, Huzhou, Jiaxing, Jinhua, Lishui, Ningbo, Shaoxing
2024-08-01
Recruiting
A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies
NCT06066203Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
40
Beijing
2023-11-01
Recruiting
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
NCT06014073Non Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2023-09-06
Recruiting
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
NCT05806099Non-Hodgkin's Lymphoma
Beijing Mabworks Biotech Co., Ltd.
Phase 1/2
132
Beijing
2023-06-28
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
2023-04-04
Recruiting
Allogenic CD19-targeting CAR-ฮณฮดT Cell Therapy in R/R NHL
NCT05554939Non Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2022-12-11
Recruiting
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05623982Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
40
Beijing, Haerbin, Qingdao
2022-09-26
Recruiting
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
NCT04662294Acute Myeloid Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma
Zhejiang University
Phase EARLY_PHASE1
108
Hangzhou
2021-11-18
Recruiting
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies
NCT04532203Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
Zhejiang University
Phase EARLY_PHASE1
72
Hangzhou
2020-11-01
Recruiting
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT04586478Non-Hodgkin's Lymphoma
Juventas Cell Therapy Ltd.
Phase 2
60
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Jinan, Shanghai, Chengdu
2020-10-26
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
AbbVie
Phase 3
165
2019-09-06
Recruiting
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
NCT02848274Mycosis Fungoides, Non-Hodgkin's Lymphoma
Stanford University
Observational
2,000
Beijing
2016-10
Recruiting
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
NCT02259556Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2014-10
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/non-hodgkin-s-lymphoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Non-Hodgkin's Lymphoma.

How many Non-Hodgkin's Lymphoma trials are recruiting in China?

12 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Non-Hodgkin's Lymphoma), 15 studies
PhaseStudiesRecruitingShare
Phase 1/27646.7%
Phase 12113.3%
Phase 32113.3%
Phase EARLY_PHASE12213.3%
Observational116.7%
Phase 2116.7%

Most active sponsors

Lead sponsors with the most studies (Non-Hodgkin's Lymphoma)
Lead sponsorStudiesRecruiting
Chinese PLA General Hospital44
AbbVie20
Sichuan Baili Pharmaceutical Co., Ltd.22
Zhejiang University22
Beijing Mabworks Biotech Co., Ltd.11
Hoffmann-La Roche10
Juventas Cell Therapy Ltd.11
Stanford University11
The Affiliated People's Hospital of Ningbo University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.